NEXGEL Appoints Former CFO Adam Drapczuk III as Interim Chief Financial Officer
NXGL sits 19% above its 52-week low of $1.45.
Summary
NEXGEL, INC. has appointed Adam E. Drapczuk III, a former CFO and recent consultant, as its Interim Chief Financial Officer, replacing Joseph F. McGuire.
Key Events · Executive and Board Changes · NXGL
-
Interim CFO Appointment
Adam E. Drapczuk III has been appointed Interim Chief Financial Officer, principal financial officer, and principal accounting officer, effective January 1, 2026.
-
Previous CFO Replaced
Mr. Drapczuk replaces Joseph F. McGuire, whose employment with the company terminated on December 31, 2025. Details of Mr. McGuire's separation are pending and will be filed in a future 8-K/A.
-
New CFO's Background
Mr. Drapczuk previously served as NEXGEL's CFO from June 2021 to December 2024 and as a financial consultant from January 2025 to December 2025, bringing prior company knowledge to the role.
-
Compensation Details
Mr. Drapczuk will receive annual cash compensation of $200,000 and is owed approximately $93,000 from his prior consulting role. An equity grant under the company's 2019 Long-Term Incentive Plan is also intended.
Analysis · NXGL · Industrial Applications And Services
NEXGEL, INC. has appointed Adam E. Drapczuk III as its Interim Chief Financial Officer, principal financial officer, and principal accounting officer. This is an important executive change, though the impact is somewhat mitigated by Mr. Drapczuk's prior experience as the company's CFO and recent financial consultant, suggesting continuity and familiarity with the company's operations. The departure of the previous CFO, Joseph F. McGuire, with details of his separation to be filed later, introduces a degree of uncertainty. Investors should monitor the upcoming 8-K/A for further information regarding Mr. McGuire's exit and the terms of Mr. Drapczuk's planned equity grant.
At the time of this filing, NXGL was trading at $1.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $18.5M. The 52-week trading range was $1.45 to $4.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.